XML 52 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Long-Term Investments (Details)
3 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Aug. 31, 2017
Ownership percentage     73.00%
Braingenesis Biotechnology Co., Ltd [Member]      
Ownership percentage 0.17% 0.17%  
Accounting treatments Cost Method    
Genepharm Biotech Corporation [Member]      
Ownership percentage 0.72% 0.72%  
Accounting treatments Cost Method    
BioHopeKing Corporation [Member]      
Ownership percentage 7.13% 7.13%  
Accounting treatments Cost Method    
BioFirst Corporation [Member]      
Ownership percentage 15.89% 15.89%  
Accounting treatments Equity Method    
Rgene Corporation [Member]      
Ownership percentage 31.61% 31.61%  
Accounting treatments Equity Method